Pure Global AI
NCT06229756Recruitment Completed

Clinical Results of Asqelio™ EDOF Toric Soft Hydrophobic Intraocular Lens After Cataract Surgery

AST Products, Inc.ClinicalTrials.gov
Verified
Study focus
Disease/Condition
Cataract
Study type
Observational
Sponsor & location
Primary sponsor
AST Products, Inc.
Location
Alicante, Spain
Timeline & enrollment
Phase
N/A
Start date
Oct 26, 2022
End date
Apr 01, 2024
Enrollment
30 participants
Primary outcome

Uncorrected Monocular Visual acuity for distance,Uncorrected Monocular Visual acuity for intermediate distance,Uncorrected Monocular Visual acuity for near distance,Corrected Monocular Visual acuity for distance,Corrected Monocular Visual acuity for intermediate distance,Corrected Monocular Visual acuity for near distance,Refractive error

Summary

The goal of this observational study is to assess the clinical outcomes of binocular
 implantation of Asqelio EDOF Toric IOLs in healthy cataract patients. The main questions it
 aims to answer are:
 
 - What is the visual performance at different distances 3 months after implantation of
 Asqelio EDOF Toric in both eyes?
 
 - What is the amount of residual refractive error following the implantation?
 
 - What is the contrast sensitivity of patients 3 months after implantation of Asqelio EDOF
 Toric in both eyes?
 
 - What is the optical quality of the eye implanted with Asqelio EDOF Toric IOL?
 
 - What is the incidence and severity of visual symptoms after implantation of Asqelio EDOF
 Toric?
 
 - What is the level of patient satisfaction after implantation of Asqelio EDOF Toric?
 
 For this purpose, participants will be submitted to a comprehensive visual and refractive
 assessment, following common clinical practice, 3 months after binocular implantation of
 Asqelio EDOF Toric IOLs, and asked to complete visual symptoms and patient satisfaction
 questionnaires.

ICD-10 classifications
Other cataractCataract, unspecifiedComplicated cataractOther specified cataractSenile cataract
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06229756
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06229756 through Pure Global AI's free database. This phase not specified trial is sponsored by AST Products, Inc. and is currently Recruitment Completed. The study focuses on Cataract. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.